USR Barcelona

RESPONSABLE
fundanet_file_Investigador4053-2
Daniel Martínez Laguna
dmartinezl.bcn.ics@gencat.cat
avatar_grups_recerca.png

Projects

Group projects

AN INTERVENTIONAL EFFICACY AND SAFETY, PHASE 2/3, DOUBLE-BLIND, 2ARM STUDY TO INVESTIGATE ORALLY ADMINISTERED PF07321332/RITONAVIR COMPARED WITH PLACEBO IN NONHOSPITALIZED SYMPTOMATIC ADULT PARTICIPANTS WITH COVID-19 WHO ARE AT LOW RISK OF PROGRESSING TO SEVERE ILLNESS

  • Principal investigators: Ernest Vinyoles Bargalló
  • Code: 5A21/021
  • Start year: 2021

A PHASE 2/3, RANDOMIZED, DOUBLE-BLIND, DOUBLE DUMMY, PLACEBO CONTROLLED STUDY TO EVALUATE THE SAFETY AND EFFICACY OF 2 REGIMENS OF ORALLY ADMINISTERED PF07321332/RITONAVIR IN PREVENTING SYMPTOMATIC SARS-COV-2 INFECTION IN ADULT HOUSEHOLD CONTACTS OF INDIVIDUALS WITH SARS-COV-2 INFECTION

  • Principal investigators: Ernest Vinyoles Bargalló
  • Code: 5A21/023
  • Start year: 2021

Valor pronòstic del monitoratge ambulatori de pressió arterial de 24 hores sobre la incidència d?esdeveniments cardiovasculars en pacients en prevenció primària cardiovascular.

  • Principal investigators: Clara Puig Pera
  • Code: 7Z20/007
  • Start year: 2020
  • Funders: ICS - Institut Català de la Salut

Investigación en insuficiencia cardíaca en atención primaria

  • Principal investigators: José María Verdú Rotellar
  • Code: 7Z21/006
  • Start year: 2021
  • Funders: ICS - Institut Català de la Salut

Premi trajectòria Investigadora AP Miguel A. Muñoz

  • Principal investigators: Miguel Angel Muñoz Pérez, Miguel Angel Muñoz Pérez
  • Code: 9F20/005
  • Start year: 2020
  • Funders: ICS - Institut Català de la Salut